Identity, Purity and Assay: What Each Result Establishes

Identity asks whether the material matches the stated compound. Purity describes a defined impurity profile. Assay measures an amount, concentration or activity using a specified procedure. These results can support one another, but they answer different questions.

Three questions to keep separate

Three questions to keep separate
AttributeQuestionWhat the report needs to establish
IdentityDoes this match the stated compound?A suitably discriminating comparison with the expected structure or reference. A matching retention time alone is insufficient. [A1]
Chromatographic purityHow much of the included chromatographic signal belongs to the assigned main peak?The method, detector, integration and calculation basis. An area percentage is not automatically a mass percentage. [A4]
Content assayHow much of the stated compound was measured?A quantitative procedure, its reference or calibration basis, and an explicit unit and reporting basis. [A1]

The word purity needs a qualifier. HPLC area purity is one measurement; it does not describe every substance that might be present. Similarly, “assay” can mean a content measurement or a biological activity measurement. Read what was measured before comparing two results with the same label. ICH Q6B treats biological potency and quantity as distinct attributes, although a justified relationship can sometimes be established. [A3]

A worked example: three results, three conclusions

The following is an invented teaching example, not a Knockout Labs certificate or a product specification. Assume the documents concern the same sample and the methods are suitable for their stated purposes.

A worked example: three results, three conclusions
Hypothetical entrySupported readingUnsupported extension
Identity: consistent with referenceThe comparison supports the identity within that method’s discrimination.Every structural detail has been independently proved.
HPLC area purity: 99.2%The assigned main peak accounts for 99.2% of the included peak area.The container is 99.2% compound by mass.
Content assay: 8.0 mg per containerThe assay reports 8.0 mg on its stated basis.The 99.2% figure should be multiplied by the labelled fill to calculate content.

There is no contradiction simply because one result is a percentage and another is a mass. They have different denominators. The purity calculation compares detector signals; the content result concerns the amount measured in the sample. For the detailed distinction between gross material and compound content, see net peptide content.

If a label states a different mass from the assay, first establish whether both values refer to the same chemical form and reporting basis. Do not explain away a discrepancy by assuming it is water, a counter-ion or solvent. Those explanations require their own evidence; assay, water content and residual solvents covers that question.

Why identity needs its own evidence

A clean-looking chromatogram could belong to a different compound. Identification needs enough discrimination to separate the intended material from relevant alternatives. ICH Q6A specifically cautions against relying on a single chromatographic retention time for identification and recognises combinations of methods. [A1]

Use why purity does not prove identity for that distinction. Where a report uses a mass match, mass spectrometry and compound identity explains the remaining questions about charge, sequence order and stereochemistry.

A percentage needs a method behind it

Ask which signal was measured, which peaks entered the calculation and whether the method separated relevant components. A number copied without those details loses much of its meaning. HPLC analysis explained shows the calculation and its limits.

For a quantitative result, method performance also matters. Selectivity concerns interference from other substances; accuracy concerns agreement with an accepted reference value; precision concerns agreement between repeated measurements. Repeatedly obtaining a similar number does not, on its own, establish that the number is accurate. These are separate validation characteristics in ICH Q2(R2). [A2]

Read the batch record in this order

  1. Match the sample. Check product identity, chemical form, lot code and laboratory report identifier. A report for another lot does not fill a gap in this one.
  2. Read each result with its method and unit. Separate identity findings, chromatographic percentages and quantitative content. Record an unreported result as unreported.
  3. Check the comparison basis. Look for the reference, specification, reporting basis and applicable limits. A “pass” without its criterion leaves a question unanswered.
  4. Keep the conclusion within the evidence. Do not turn one measured attribute into a claim about all quality attributes or suitability for an experiment.

The analytical testing methods guide helps identify the kind of evidence to request. The quality documentation hub explains the wider record, and batch reports provides the route for asking what is available for the exact lot. For packaging wording, read how the 99%+ purity claim must be substantiated.

References

Sources explain analytical principles. Pharmaceutical guidance is not evidence that a research material or supplier meets those standards. Examples on this page are hypothetical.

  1. [A1] ICH Q6A: Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances. 1999. Sections 3.2.1(b–c), 3.2.2(b).
  2. [A2] ICH Q2(R2): Validation of Analytical Procedures. FDA publication, March 2024. Table 1; sections 3.1, 3.3 and glossary.
  3. [A3] ICH Q6B: Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. 1999. Sections 2.1.5, 4.1.4–4.1.5 and glossary.
  4. [A4] Agilent OpenLab CDS: Data Analysis Reference Guide. February 2019, revision C. Integration chapters; printed pages 137–138, Area% and calibrated quantitation.

Sources accessed 23 October 2026.